跳至主要内容
临床试验/NCT06395454
NCT06395454尚未招募不适用

Procalcitonin as a Sepsis Biomarker in Guiding Antibiotics Treatment Duration in Ventilator Associated Pneumonia in Neuro-ICU: A Randomised Controlled Trial

Universiti Sains Malaysia0 个研究点目标入组 48 人开始时间: 2024年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
48
主要终点
To compare the duration of antibiotics between PCT versus Standard of care guided stopping antibiotic

研究概览

简要总结

Using Procalcitonin Tests to reduce antibiotics duration in Neurosurgical patients with Ventilated Associated Pneumonia

详细描述

Patients who are more than 18 years old who are admitted to Neurosurgical ICU will be recruited 48hours after ventilation if matches criteria for ventilator associated pneumonia. Patients will be randomised into 2 groups. first group will be procalcitonin guided in addition to conventionally guided sepsis assessment (TWC, CRP, body temperature). second group is only conventionally guided sepsis assessment. in procalcitonin guided group, blood sample will be taken on Day 1 of recruitment and day 5. On day 5 , the procalcitonin level will be compared to recommendations in PRORATA trial. If procalcitonin level is below the level to withhold antibiotics, recommendation will be made to the primary physician to off the antibiotics. Another Procalcitonin level will be repeated on Day 7 to rule out reinfection. This study aims to compare the duration of antibiotics and length of ICU stay among the 2 groups.

This study will fill up the gap among the lack of datas in neurosurgical patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients admitted to Neuro-ICU & Trauma ICU
  • Patients aged >18 years old.
  • Ventilation for >48 hours
  • VAP and treated with antibiotics <24hours prior to inclusion in trial.
  • Patient with arterial line or central line

排除标准

  • Patients who are on antibiotics but not assumed or proven to have VAP
  • Expected short ICU stay (<3 Days)
  • Non-bacterial infections
  • Long term antibiotic treatment (transplant or chemotherapy patients, endocarditis, osteomyelitis)
  • Hospitalisation 48hours before enrolment
  • Severe immunosuppression
  • Pregnancy
  • Primary team's decision to continue antibiotics for 14 days prior to trial
  • DNAR or expected to die within 5 days

结局指标

主要结局

To compare the duration of antibiotics between PCT versus Standard of care guided stopping antibiotic

时间窗: 14 days

compare the duration of antibiotics between 2 arms

To compare the length of ICU stay in between PCT versus Standard of care guided stopping antibiotic

时间窗: 14 days

compare the length of ICU stay in between 2 arms

次要结局

  • To compare 14 days mortality rate in between 2 arms(14 days)
  • To compare the proportion of reinfection within 72 hours after stopping antibiotics(14 days)
  • To compare proportion of difficult to treat organisms (MRO) in between 2 arms(14 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mohd Zulfakar Mazlan, MBBS

Associate Professor Dr

Universiti Sains Malaysia

相似试验